BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, February 12, 2026
Home
»
Topics
»
Disease categories and therapies
» Urology
Urology
RSS
Merck returns alpha-adrenergic technology rights to Synaptic
March 7, 2000
C5 inhibitor from Alexion granted fast track status for kidney disease
March 2, 2000
Dosing begins in phase II trial of Alprox-TD for erectile dysfunction
Feb. 28, 2000
Nastech's intranasal apomorphine compared to Viagra in phase II pilot trial
Feb. 25, 2000
Synaptic discovers potent and selective human alpha1D-adrenoceptor antagonists
Feb. 24, 2000
Potent and selective alpha1D-adrenoceptor antagonists presented by Abbott
Feb. 18, 2000
Cortex receives notice of allowance for sexual dysfunction patent
Feb. 16, 2000
Preclinical studies support potential new indication for tamsulosin
Feb. 14, 2000
Kissei compounds display excellent beta3-adrenoceptor-stimulating effects
Feb. 11, 2000
Nastech claims formulations of sildenafil for nasal delivery
Feb. 11, 2000
Previous
1
2
…
267
268
269
270
271
272
273
274
275
…
318
319
Next
RSS